Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 3/20 | 1.00 |
| ▸ | ADORA2A | P29274 | 2/20 | 1.00 |
| ▸ | AURKA | O14965 | 1/20 | 1.00 |
| ▸ | PRKACA | P17612 | 1/20 | 1.00 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.67 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.67 |
| ▸ | RAB9A | P51151 | 3/20 | 0.61 |
| ▸ | NPC1 | O15118 | 1/20 | 0.61 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.59 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.58 |
| ▸ | RAF1 | P04049 | 1/20 | 0.58 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.58 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.58 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.58 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.58 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.55 |
| ▸ | KMO | O15229 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL17186384 | 0.98 | HSP90AA1 (0.96) | HSP90AA1ADORA2AAURKAPRKACAHSP90AB1 | |
| SCHEMBL12176972 | 0.96 | HSP90AA1 (0.92) | HSP90AA1ADORA2AAURKAPRKACAHSP90AB1 | |
| SCHEMBL4202167 | 0.87 | HSP90AA1 (0.76) | HSP90AA1ADORA2AAURKAPRKACAHSP90AB1 | |
| Trifluoroacetic Acid SCHEMBL28137418 | 0.85 | HSP90AA1 (0.72) | HSP90AA1ADORA2AAURKAPRKACAHSP90AB1 | |
| SCHEMBL28013042 | 0.84 | HSP90AA1 (0.71) | HSP90AA1ADORA2AAURKAPRKACAHSP90AB1 | |
| SCHEMBL21164006 | 0.83 | HSP90AA1 (0.70) | HSP90AA1ADORA2AAURKAPRKACAHSP90AB1 | |
| SCHEMBL2684649 | 0.83 | HSP90AA1 (0.70) | HSP90AA1ADORA2AAURKAPRKACAHSP90AB1 | |
| SCHEMBL712182 | 0.82 | HSP90AA1 (0.69) | HSP90AA1ADORA2AAURKAPRKACAHSP90AB1 | |
| Morpholine SCHEMBL28118737 | 0.82 | HSP90AA1 (0.68) | HSP90AA1ADORA2AAURKAPRKACAHSP90AB1 | |
| SCHEMBL4708076 | 0.80 | HSP90AA1 (0.67) | HSP90AA1ADORA2AAURKAPRKACAHSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 698 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112898208-B | Phenylpyrimidine amine antitumor compound and preparation method and application thereof | 中国医科大学 | 2023-06-20 | — | — | CN | claimed |
| CN-112898208-A | Phenyl pyrimidinamine antitumor compound and preparation method and application thereof | 中国医科大学 | 2021-06-04 | — | — | CN | claimed |
| US-10988461-B2 | Small molecule IRE1-α inhibitors | CORNELL UNIVERSITY (US) | 2021-04-27 | — | — | US | claimed |
| EP-2949647-B1 | DEUTERATED PHENYL AMINO PYRIMIDINE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | SUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD (CN) | 2020-08-05 | — | — | EP | claimed |
| WO-2019134082-A1 | NOVEL PYRIMIDINE DERIVATIVES AS MTH1 INHIBITORS | WUXI ADVANT BIOTECHNOLOGY CO., LTD. (CN) | 2019-07-11 | — | — | WO | claimed |
| CN-109651366-A | The preparation method of nitrogen-containing heterocycle hexafluoro borate | 河南师范大学 | 2019-04-19 | — | — | CN | claimed |
| US-20190016706-A1 | SMALL MOLECULE IRE1-ALPHA INHIBITORS | CORNELL UNIVERSITY | 2019-01-17 | — | — | US | claimed |
| EP-3389633-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING PHENYLAMINOPYRIMIDINE DERIVATIVE | Natco Pharma Limited (IN) | 2018-10-24 | — | — | EP | claimed |
| CN-108495620-A | Pharmaceutical compositions comprising phenylaminopyrimidine derivatives | 纳科制药有限公司 | 2018-09-04 | — | — | CN | claimed |
| CN-105399685-B | The alternatively preparation method and applications of the heteroaromatic compounds of property JAK3 and/or JAK1 kinase inhibitors | 深圳微芯生物科技有限责任公司 | 2018-05-22 | — | — | CN | claimed |
| CN-103965114-B | Deuterated phenyl amino pyrimidine compounds and comprise the pharmaceutical composition of this compound | SUZHOU ZELGEN BIOPHARMACEUTICALS CO., LTD. (CN) | 2016-01-06 | — | — | CN | claimed |
| EP-2949647-A1 | DEUTERATED PHENYL AMINO PYRIMIDINE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Suzhou Zelgen Biopharmaceuticals Co. Ltd. (CN) | 2015-12-02 | — | — | EP | claimed |
| CN-104955811-A | Deuterated phenylaminopyrimidine compounds and pharmaceutical compositions containing same | SUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD | 2015-09-30 | — | — | CN | claimed |
| CN-104447706-A | 4-phenyl-2-aminopyrimidine compound, as well as preparation method and applications thereof | UNIV SHANDONG | 2015-03-25 | — | — | CN | claimed |
| CN-103965114-A | Deuterated phenylamino pyrimidine compound and drug composition containing the same | SUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD | 2014-08-06 | — | — | CN | claimed |
| CN-103044394-A | Phenyl aminopyrimidine derivant and preparation method and application thereof | BEIJING INST TECHNOLOGY | 2013-04-17 | — | — | CN | claimed |
| CN-101068805-A | Novel phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase | NATCO PHARMA LTD (IN) | 2007-11-07 | — | — | CN | claimed |
| EP-1597398-A1 | TAILORED TREATMENT SUITABLE FOR DIFFERENT FORMS OF MASTOCYTOSIS | AB Science (FR) | 2005-11-23 | — | — | EP | claimed |
| WO-2004098612-A2 | CALCITRIOL ANALOGS OF USES THEREOF | AB SCIENCE (FR) | 2004-11-18 | — | — | WO | claimed |
| WO-2004076693-A1 | TAILORED TREATMENT SUITABLE FOR DIFFERENT FORMS OF MASTOCYTOSIS | AB SCIENCE (FR) | 2004-09-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190016706-A1 | SMALL MOLECULE IRE1-ALPHA INHIBITORS | XBP1, ERN1, ERN2 | HSP90AA1 129/4885ADORA2A 4636/4885AURKA 3183/4885 |
| US-10988461-B2 | Small molecule IRE1-α inhibitors | XBP1, ERN1, ERN2 | HSP90AA1 118/4885ADORA2A 4557/4885AURKA 3069/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.